Dr. Ziad A. Khatib
Claim this profileNicklaus Children's Hospital
Expert in Brain Tumor
Expert in Tumors
41 reported clinical trials
86 drugs studied
About Ziad A. Khatib
Education:
- Earned an MD from the American University of Beirut, Lebanon.
Experience:
- Completed residency at Jackson Memorial Hospital, Miami.
- Undertook a fellowship in hematology-oncology at St. Jude Children's Research Hospital, Memphis, Tennessee.
- Serves as Vice President of Medical Staff at Nicklaus Children's Hospital, with over 24 years of practice.
- Holds a position as Clinical Associate Professor at Florida International University Herbert Wertheim College of Medicine.
- Actively participates in pediatric cancer research, focusing on brain tumors.
Area of expertise
1Brain Tumor
Global LeaderStage IV
Stage I
Stage II
2Tumors
Global LeaderStage I
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Ziad A. Khatib is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
More about Ziad A. Khatib
Clinical Trial Related4 years of experience running clinical trials · Led 41 trials as a Principal Investigator · 17 Active Clinical TrialsTreatments Ziad A. Khatib has experience with
- Cyclophosphamide
- Radiation Therapy
- Cisplatin
- Carboplatin
- Etoposide
- Larotrectinib
Breakdown of trials Ziad A. Khatib has run
Brain Tumor
Tumors
Germ Cell Tumors
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ziad A. Khatib specialize in?
Ziad A. Khatib focuses on Brain Tumor and Tumors. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are Stage I.
Is Ziad A. Khatib currently recruiting for clinical trials?
Yes, Ziad A. Khatib is currently recruiting for 15 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Ziad A. Khatib has studied deeply?
Yes, Ziad A. Khatib has studied treatments such as Cyclophosphamide, Radiation Therapy, Cisplatin.
What is the best way to schedule an appointment with Ziad A. Khatib?
Apply for one of the trials that Ziad A. Khatib is conducting.
What is the office address of Ziad A. Khatib?
The office of Ziad A. Khatib is located at: Nicklaus Children's Hospital, Miami, Florida 33155 United States. This is the address for their practice at the Nicklaus Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.